Description
This product utilizes Synthetic CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target IL21R (clone 1G8PG4I). We employs the HBV (SV40-Cy2-GR-BamHI) vector components and the SynExpress system of the Introns Substitution/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
IL21R
Clone
1G8PG4I
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
Cy2
Promoter
SV40
Effector Gene
GR
Insertion Sites
BamHI
Gene Modification
Substitution
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.96
Cell Culture
Aseptic Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.